Press Esc to close

Welcome to Money Morning - Only the News You Can Profit From.

Close

This Says Our Favorite Biotech Is Off to the Races

Shares of a promising biotech we recommended back in February 2013 – jumped as much as 27% to a three-month high of $14.20 yesterday after the company said a new cancer drug met its main goal in a midstage clinical trial.

Its shares backtracked a bit as the day progressed but still closed 17.6% higher for the session. These shares have advanced 361% since we first told you about them. The stock has generated a peak gain of 456%, making it one of the 31 recommendations we’ve made to you that have doubled or better since we launched Private Briefing in August 2011. (More on that later…)

  • Is America's Middle Class Caught in a Vise? With the housing bust and the market collapse, middle class Americans lost 47% of their wealth of between 2007 and 2010. And now they seem to be doing it again.... Read More...
  • Middle Class Decline Under Obama Shown in 5 Charts Chart down small In his second inauguration speech Monday, President Obama reiterated Monday how important the middle class is to our economic growth. Yet the financial reality that now faces this group is uglier than ever. Read More...